| ACE-i | angiotensin-converting enzyme inhibitor |
| ACS | acute coronary syndrome |
| ADL | activities of daily living |
| APTT | activated partial thromboplastin time |
| ARB | angiotensin II receptor blocker |
| AUC | area under the curve |
| AVK | antivitamin K |
| BP | blood pressure |
| BUN | blood urea nitrogen |
| CAD | coronary artery disease |
| CI | confidence interval |
| CKD | chronic kidney disease |
| COPD | chronic obstructive pulmonary disease |
| CPD | chronic pulmonary disease |
| CRP | C-reactive protein |
| CRT | cardiac resynchronization therapy |
| CTA | computed tomography angiography |
| CVRF | cardiovascular risk factor |
| CURB-65 | confusion, BUN, respiratory rate, systolic blood pressure, age ≥ 65 |
| DOAC | direct oral anticoagulant |
| DVT | deep venous thrombosis |
| ECG | electrocardiogram |
| ED | emergency department |
| HCQ | hydroxychloroquine |
| ICD | implantable cardiac device |
| ICU | intensive care unit |
| INR | international normalized ratio |
| IQR | interquartile range |
| LVEF | left ventricular ejection fraction |
| MI | myocardial infarction |
| MRA | mineralocorticoid receptor antagonist |
| no | number |
| OAD | oral antidiabetic |
| OSAS | obstructive sleep apnea syndrome |
| OR | odds ratio |
| PE | pulmonary embolism |
| RAAS | renin-angiotensin-aldosterone system |
| ROC | receiver operating characteristic |
| RT-PCR | reverse transcriptase-polymerase chain reaction |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| SD | standard deviation |
| SE | standard error |
| TIA | transient ischaemic attack |
| TnI | troponin I |
| T2DM | type-2 diabetes mellitus |
| SARS-CoV-2 | severe acute respiratory syndrome-coronavirus 2 |